Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease

Abstract

Metrifonate was safe and well-tolerated. It enhanced not only the cognitive and global function, but also the behavioral function of patients diagnosed with mild to moderate AD. Therefore, metrifonate appears to be useful in the symptomatic treatment of AD.